Recent News

By Category: Bioterrorism

FDA Lifts Clinical Hold On PharmAthene’s SparVax(R) Anthrax Vaccine Program

(TheWallStreetJournal) PharmAthene, Inc. (NYSE MKT: PIP), a biodefense company developing medical countermeasures against biological and chemical threats, announced today that the U.S. Food and Drug Administration (FDA) has lifted the clinical hold previously placed on a proposed Phase II study of SparVax(R) , a next generation recombinant anthrax vaccine. “We are very pleased by the Read More »

May 31, 2013
| Filed under North America, Agents & Toxins, Biological Weapons, Bioterrorism, Countermeasures, Public Health, and Research
Share

Experimental Drug Could Treat Child Bioterrorism Victims

(GlobalSecurityNewswire) The United States on Friday announced a $17.7 million push to secure federal licensure of an experimental antibiotic officials believe could treat young victims of anthrax or tularemia bacteria. Announcement of the two-year research and development deal with a North Carolina pharmaceutical firm came weeks after congressional investigators warned that minors could have only Read More »

May 29, 2013
| Filed under North America, Agents & Toxins, Biological Weapons, Bioterrorism, Countermeasures, Policy & Initiatives, and Research
Share

BARDA Partners with GSK for Hospital and Biothreat Antibacterials

(GlobalBiodefense) The U.S. Department of Health and Human Services, Biomedical Advanced Research and Development Authority (BARDA) has entered into a collaborative agreement with Glaxo Smith Kline (GSK) to evaluate the efficacy and safety of the company’s portfolio of clinical stage antibacterial assets for treating hospital and biothreat infections. The contract is unique in that it Read More »

May 24, 2013
| Filed under North America, Bioterrorism, Policy & Initiatives, Public Health, and Research
Share

EXCLUSIVE: Wrongly Accused Ricin Suspect Speaks Out – WJTV-TV: News, Weather, and Sports for Jackson, MS

May 22, 2013
| Filed under Bioterrorism
Share

Three day metro-wide disaster drill will simulate bioterrorism attack

(The Oregonian) As preparedness drills go, the 3-day PACE (Portland Area Capabilities Exercise) Setter bioterrorism exercise that starts Tuesday is big. The exercise–which simulates a terrorist attack involving a biological weapon–will unfold across 50 different venues and some 65 jurisdictions from Gresham to Tigard.